Finally, we used GSEA and TIMER database analysis to explore the possible mechanism of ITGB3BP in glioma and identified potential therapeutic compounds that may target ITGB3BP by CMap analysis. The gene discussed is ITGB3BP; the disease is central nervous system cancer.